Why is Neogen stock surging today?
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Neogen Corporation (NEOG)
Neogen Corporation stock price live, this page displays NASDAQ NEOG stock exchange data. View the NEOG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Neogen Corporation real time stock price chart below.
What Is the Neogen Corporation Stock Price Today?
The Neogen Corporation stock price today is 11,81.
What Is the Stock Symbol for Neogen Corporation?
The stock symbol for Neogen Corporation is "NEOG."
What Stock Exchange Does Neogen Corporation Trade On?
Neogen Corporation is listed and trades on the NASDAQ stock exchange.
Is Neogen Corporation a Good Stock to Buy?
Determining whether Neogen Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NEOG quote. (ISIN: US6404911066)
What Is the Neogen Corporation Stock Price Today?
The Neogen Corporation stock price today is 11,81.
What Is the Stock Symbol for Neogen Corporation?
The stock symbol for Neogen Corporation is "NEOG."
What Stock Exchange Does Neogen Corporation Trade On?
Neogen Corporation is listed and trades on the NASDAQ stock exchange.
Is Neogen Corporation a Good Stock to Buy?
Determining whether Neogen Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NEOG quote. (ISIN: US6404911066)
11.81
+0.10(+0.81%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.57
12.11
52 wk Range
5.37
14.26
NEOG is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.5712.11
52 wk Range
5.3714.26
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NEOG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
14.00
Upside
+18.54%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price movements are quite volatile
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Analyst Ratings
3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 14.00
(+18.54% Upside)
Neogen Corporation Earnings Call Summary for Q1/2027
- Neogen reported Q1 FY2027 adjusted EPS of $0.08 on revenue of $222.8M, beating estimates of $0.05 and $204.7M; core revenue rose 8.1% year-over-year.
- Company raised full-year guidance to $885M-$890M revenue and $181M-$183M adjusted EBITDA; adjusted EBITDA margin expanded 170 bps to 18.7%.
- Management expects Q2 to be weakest of year due to timing effects; first-half core growth projected at 3.5% with H1 EBITDA margins around 18.7%.
- Petrifilm manufacturing transfer on track to begin next month; duplicative costs to peak then ease, targeting 200-300 bps margin improvement by FY2029.
- Genomics divestiture expected to yield $140M net proceeds by December pending regulatory review; stock surged 9.7% after-hours following 8% regular session decline.
Last Updated: 2026/10/06, 23:20
Read Full TranscriptEarnings
Latest Release
Oct 06, 2026
EPS / Forecast
0,08 / 0,05
Revenue / Forecast
222,8M / 204,7M
Compare NEOG to Peers and Sector
Metrics to compare | NEOG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNEOGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −45.6x | −14.2x | −0.3x | |
PEG Ratio | −0.48 | −0.83 | 0.00 | |
Price/Book | 1.2x | 2.0x | 2.6x | |
Price / LTM Sales | 2.9x | 2.4x | 3.0x | |
Upside (Analyst Target) | 19.6% | 15.1% | 62.0% | |
Fair Value Upside | Unlock | −8.1% | 8.2% | Unlock |
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis. The company has a strategic collaboration with Hinalea Imaging Corp. to develop digital imaging solutions for food safety and quality inspection. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Neogen (NEOG) Stock Price Today?
The Neogen stock price today is 11,81 USD.
What Stock Exchange Does Neogen Trade On?
Neogen is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Neogen?
The stock symbol for Neogen is "NEOG."
What Is the Neogen Market Cap?
As of today, Neogen market cap is 2,57B USD.
What Is Neogen's Earnings Per Share (TTM)?
The Neogen EPS (TTM) is -0,26.
When Is the Next Neogen Earnings Date?
Neogen will release its next earnings report on Jan 14, 2027.
From a Technical Analysis Perspective, Is NEOG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Neogen Stock Split?
Neogen has split 6 times.
How Many Employees Does Neogen Have?
Neogen has 2636 employees.
What is the current trading status of Neogen (NEOG)?
As of Oct 09, 2026, Neogen (NEOG) is trading at a price of 11,81 USD, with a previous close of 11,71 USD. The stock has fluctuated within a day range of 11,57 USD to 12,11 USD, while its 52-week range spans from 5,37 USD to 14,26 USD.
What Is Neogen (NEOG) Price Target According to Analysts?
The average 12-month price target for Neogen is 14,00 USD, with a high estimate of 14 USD and a low estimate of 14 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +18,54% Upside potential.
What Is the NEOG Premarket Price?
NEOG's last pre-market stock price is 11,75 USD. The pre-market share volume is 1 500,00, and the stock has decreased by 0,04, or 0,34%.
What Is the NEOG After Hours Price?
NEOG's last after hours stock price is 11,50 USD, the stock has decreased by -0,21, or -1,79%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.